Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 5Recruiting 2Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Breast 5Gynecologic 1

Conditions

Breast Neoplasms 5Colorectal Neoplasms 4Hematologic Neoplasms 3Prostatic Neoplasms 2Motor Activity 2Lung Neoplasms 2Hodgkin Disease 2Hematopoietic and Lymphoid System Neoplasm 2Carcinoma, Non-Small-Cell Lung 2Trastuzumab Cardiotoxicity 1Stress Disorders, Post-Traumatic 1Sleep Wake Disorders 1Sedentary Behavior 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Myocardial Fibrosis 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Insulin Resistance 1Hereditary Breast and Ovarian Cancer Syndrome 1Heart Diseases 1Head and Neck Neoplasms 1Gastrointestinal Diseases 1Fatigue 1Esophageal Neoplasms 1Dyslipidemias 1Depression 1

Interventions

Trastuzumab 351Paclitaxel 334Cyclophosphamide 315Docetaxel 292Capecitabine 181Doxorubicin 180Letrozole 165Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 83Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 68Filgrastim 64Albumin-Bound Paclitaxel 64Magnetic Resonance Spectroscopy 56eribulin 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Exercise Test × Clear all
NCT01186367 2025-02-10

Excite

Memorial Sloan Kettering Cancer Center

Phase NA Completed
174 enrolled 11 charts
Breast

Breast Neoplasms

NCT03510689 2024-10-16

Gene-HEART

Abramson Cancer Center at Penn Medicine

Completed
79 enrolled
BreastGynecologic

Breast Neoplasms, Heart Diseases, Hereditary Breast and Ovarian Cancer Syndrome

NCT01719562 2023-05-19

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Wake Forest University Health Sciences

Phase NA Completed
28 enrolled 17 charts
Breast

Breast Neoplasms, Neoplasms, Cardiotoxicity

NCT01725633 2023-04-06

Breast Mets

Memorial Sloan Kettering Cancer Center

Phase NA Completed
27 enrolled
Breast

Breast Neoplasms

NCT02702830 2019-04-26

MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment

Wake Forest University Health Sciences

Completed
33 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡